Velu PP et al. |
Pulmonary Mycobacterium marinum infection: 'fish tank granuloma' of the lung. |
2016 |
Scott Med J |
pmid:27872397
|
Schuster S et al. |
Evidence of a Substrate-Discriminating Entrance Channel in the Lower Porter Domain of the Multidrug Resistance Efflux Pump AcrB. |
2016 |
Antimicrob. Agents Chemother. |
pmid:27161641
|
Radzikowska E et al. |
Cryptogenic Organizing Pneumonia: IL-1β, IL-6, IL-8, and TGF- β1 Serum Concentrations and Response to Clarithromycin Treatment. |
2016 |
Adv. Exp. Med. Biol. |
pmid:26987326
|
Wu DC et al. |
A Pilot Randomized Controlled Study of Dexlansoprazole MR-Based Triple Therapy for Helicobacter Pylori Infection. |
2016 |
Medicine (Baltimore) |
pmid:26986096
|
Berlin S et al. |
Pharmacokinetics and Pulmonary Distribution of Clarithromycin and Rifampicin after Concomitant and Consecutive Administration in Foals. |
2016 |
Mol. Pharm. |
pmid:26808255
|
Geng S et al. |
Clarithromycin ion pair in a liposomal membrane to improve its stability and reduce its irritation caused by intravenous administration. |
2016 |
Expert Opin Drug Deliv |
pmid:26588710
|
Aguilera-Correa JJ et al. |
Detection of Helicobacter pylori and the genotypes of resistance to clarithromycin and the heterogeneous genotype to this antibiotic in biopsies obtained from symptomatic children. |
2017 |
Diagn. Microbiol. Infect. Dis. |
pmid:27863951
|
Katayama Y et al. |
Neuroprotective effects of clarithromycin against neuronal damage in cerebral ischemia and in cultured neuronal cells after oxygen-glucose deprivation. |
2017 |
Life Sci. |
pmid:27825902
|
Cosme A et al. |
Antimicrobial susceptibility testing before first-line treatment for infection in patients with dual or triple antibiotic resistance. |
2017 |
World J. Gastroenterol. |
pmid:28566898
|
Moj D et al. |
Clarithromycin, Midazolam, and Digoxin: Application of PBPK Modeling to Gain New Insights into Drug-Drug Interactions and Co-medication Regimens. |
2017 |
AAPS J |
pmid:27822600
|
Angol DC et al. |
from Peptic Ulcer Patients in Uganda Is Highly Resistant to Clarithromycin and Fluoroquinolones: Results of the GenoType HelicoDR Test Directly Applied on Stool. |
2017 |
Biomed Res Int |
pmid:28555193
|
Akpinar Z et al. |
Improving the standard sequential treatment of Helicobacter pylori with either extended treatment or by adding bismuth. |
2017 |
Arab J Gastroenterol |
pmid:28532623
|
Beckman E et al. |
A Novel Stool PCR Test for Helicobacter pylori May Predict Clarithromycin Resistance and Eradication of Infection at a High Rate. |
2017 |
J. Clin. Microbiol. |
pmid:28515219
|
Kajihara Y et al. |
Analysis of the cost-effectiveness of using vonoprazan-amoxicillin-clarithromycin triple therapy for first-line Helicobacter pylori eradication. |
2017 |
Scand. J. Gastroenterol. |
pmid:27806639
|
Yan J et al. |
Survey about the use of clarithromycin in an ENT outpatient department of a tertiary hospital. |
2017 |
Eur Arch Otorhinolaryngol |
pmid:28508178
|
Shaulov A et al. |
Progressive refractory light chain amyloidosis and multiple myeloma patients are responsive to the addition of clarithromycin to IMiD based therapy. |
2017 |
Am. J. Hematol. |
pmid:27804150
|
DaCosta A et al. |
Outcomes associated with antibiotic regimens for treatment of Mycobacterium abscessus in cystic fibrosis patients. |
2017 |
J. Cyst. Fibros. |
pmid:28495380
|
Sharifi R et al. |
Dietary PUFA Increase Apoptosis in Stomach of Patients with Dyspeptic Symptoms and Infected with H. pylori. |
2017 |
Lipids |
pmid:28493185
|
Reddy AB and Reddy ND |
Development of Multiple-Unit Floating Drug Delivery System of Clarithromycin: Formulation, in vitro Dissolution by Modified Dissolution Apparatus, in vivo Radiographic Studies in Human Volunteers. |
2017 |
Drug Res (Stuttg) |
pmid:28449156
|
Ivanová L et al. |
Estimation of amount of selected pharmaceuticals sorbed onto digested sludge from wastewater treatment plant Bratislava-Petržalka. |
2017 |
Environ. Res. |
pmid:28183039
|
Giguère S et al. |
Antimicrobial Resistance in . |
2017 |
Microbiol Spectr |
pmid:29052538
|
El Haj C et al. |
The anti-biofilm effect of macrolides in a rat model of S. aureus foreign-body infection: Might it be of clinical relevance? |
2017 |
Med. Microbiol. Immunol. |
pmid:27639707
|
Seyama S et al. |
Emergence and molecular characterization of Haemophilus influenzae harbouring mef(A). |
2017 |
J. Antimicrob. Chemother. |
pmid:27999037
|
Giguère S |
Treatment of Infections Caused by Rhodococcus equi. |
2017 |
Vet. Clin. North Am. Equine Pract. |
pmid:28161038
|
Berni E et al. |
Risk of cardiovascular events, arrhythmia and all-cause mortality associated with clarithromycin versus alternative antibiotics prescribed for respiratory tract infections: a retrospective cohort study. |
2017 |
BMJ Open |
pmid:28115334
|
Serrano CA et al. |
Helicobacter pylori-Clarithromycin Resistance in Symptomatic Pediatric Patients in a High Prevalence Country. |
2017 |
J. Pediatr. Gastroenterol. Nutr. |
pmid:27159208
|
Yatera K et al. |
The additive effect of clarithromycin on influenza A infection in the elderly patients and patients with comorbid diseases. |
2017 |
Respir Investig |
pmid:29153420
|
Lee MC et al. |
Antimicrobial resistance in Mycobacterium abscessus complex isolated from patients with skin and soft tissue infections at a tertiary teaching hospital in Taiwan. |
2017 |
J. Antimicrob. Chemother. |
pmid:29091186
|
Takahashi C et al. |
Morphological study of efficacy of clarithromycin-loaded nanocarriers for treatment of biofilm infection disease. |
2017 |
Med Mol Morphol |
pmid:27119723
|
Laidler N |
Cutaneous infection with paucibacillary treated successfully with a modified antituberculous drug regimen. |
2017 |
BMJ Case Rep |
pmid:29275384
|
Lee JS et al. |
Implication of species change of Nontuberculous Mycobacteria during or after treatment. |
2017 |
BMC Pulm Med |
pmid:29262802
|
Ruiter R et al. |
Helicobacter pylori resistance in the Netherlands: a growing problem? |
2017 |
Neth J Med |
pmid:29219812
|
Kim SY et al. |
Helicobacter pylori eradication rates of concomitant and sequential therapies in Korea. |
2017 |
Helicobacter |
pmid:28940815
|
Mukherjee D et al. |
Vancomycin and Clarithromycin Show Synergy against . |
2017 |
Antimicrob. Agents Chemother. |
pmid:28923867
|
Tsay FW et al. |
A Randomized Controlled Trial Shows that both 14-Day Hybrid and Bismuth Quadruple Therapies Cure Most Patients with Helicobacter pylori Infection in Populations with Moderate Antibiotic Resistance. |
2017 |
Antimicrob. Agents Chemother. |
pmid:28807915
|
Oh ES et al. |
Effects of clarithromycin on the pharmacokinetics of evogliptin in healthy volunteers. |
2017 |
J Clin Pharm Ther |
pmid:28806472
|
Kuo YT et al. |
Primary antibiotic resistance in Helicobacter pylori in the Asia-Pacific region: a systematic review and meta-analysis. |
2017 |
Lancet Gastroenterol Hepatol |
pmid:28781119
|
Ramas M et al. |
Efficacy and safety of rifaximin associated with standard triple therapy (omeprazole, clarithromycin and amoxicillin) for H. pylori eradication: A phase IV pilot clinical trial. |
2017 |
Gastroenterol Hepatol |
pmid:28780968
|
Sue S et al. |
The Superiority of Vonoprazan-based First-line Triple Therapy with Clarithromycin: A Prospective Multi-center Cohort Study on Helicobacter pylori Eradication. |
2017 |
Intern. Med. |
pmid:28566587
|
Hu Y et al. |
Novel and Effective Therapeutic Regimens for in an Era of Increasing Antibiotic Resistance. |
2017 |
Front Cell Infect Microbiol |
pmid:28529929
|
Jeong SH et al. |
Mycobacteriological characteristics and treatment outcomes in extrapulmonary Mycobacterium abscessus complex infections. |
2017 |
Int. J. Infect. Dis. |
pmid:28522316
|
Kishida D et al. |
Intractable Cutaneous Nontuberculous Mycobacteriosis (Mycobacterium abscessus) during Treatment for Systemic Lupus Erythematosus. |
2017 |
Intern. Med. |
pmid:28502947
|
Jung YS et al. |
Systematic review with meta-analysis: the efficacy of vonoprazan-based triple therapy on Helicobacter pylori eradication. |
2017 |
Aliment. Pharmacol. Ther. |
pmid:28497487
|
Sharman MJ et al. |
Gastrokine mRNA expression in gastric tissue from dogs with helicobacter colonisation but without inflammatory change during treatment. |
2017 |
Vet. Immunol. Immunopathol. |
pmid:28494926
|
O'Brien CR et al. |
Feline leprosy due to Candidatus 'Mycobacterium tarwinense':Further clinical and molecular characterisation of 15 previously reported cases and an additional 27 cases |
2017 |
J. Feline Med. Surg. |
pmid:28438086
|
Zhang Z et al. |
In vitro activity of clarithromycin in combination with other antimicrobial agents against Mycobacterium abscessus and Mycobacterium massiliense. |
2017 |
Int. J. Antimicrob. Agents |
pmid:28188830
|
Kristin F et al. |
Dissolution and dissolution/permeation experiments for predicting systemic exposure following oral administration of the BCS class II drug clarithromycin. |
2017 |
Eur J Pharm Sci |
pmid:28179133
|
Chen D et al. |
Phenotypic and Molecular Antimicrobial Susceptibility of Helicobacter pylori. |
2017 |
Antimicrob. Agents Chemother. |
pmid:28167563
|
Olesen JS et al. |
Mycobacterium chelonae hand infection after steroid injection in a patient with rheumatoid arthritis receiving long-term linezolid therapy. |
2017 |
BMJ Case Rep |
pmid:28137898
|
Chang JY et al. |
Triple therapy versus sequential therapy for the first-line Helicobacter pylori eradication. |
2017 |
BMC Gastroenterol |
pmid:28109257
|